FDA
-
-
-
-
-
-
-
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
-
-
-
-
-
-
-
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
-
-
-
-
-
-
-
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Orchestra BioMed presents data showing sustained blood pressure drops
-
-
-
-
-
-
-
Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
-
-
-
-
-
-
-
Orchestra BioMed Announces Pricing of $40 Million Public Offering
-
-
-
-
-
-
-
Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
-
330,738 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

